CTOs on the Move

Lift Brands

www.liftbrands.com

 
Lift Brands Elevated Wellness Companies is the world`s largest wellness franchise organization. We have 2,500 clubs open or in development in 26 countries and 1.5 million members world-wide. Snap Fitness has approximately 2,500 clubs open or in development in 26 countries with more than one million members. The 24/7 gyms are dedicated to providing members with a quality, convenient, and results-driven fitness solution. YogaFit Studios is a first-of-its-kind franchise concept in the fitness industry. The state-of-the-art studios offer members a variety of live and virtual on-demand classes day or night. 9Round offers 30-minute, high-intensity circuit training that combines kickboxing, traditional ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.liftbrands.com
  • 2411 Galpin Court Suite 110
    Chanhassen, MN USA 55317
  • Phone: 952.474.5422

Executives

Name Title Contact Details
Samuel Maeder
Information Security Director Profile

Similar Companies

Welch Allyn Inc.

Welch Allyn Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Skaneateles Falls, NY. To find more information about Welch Allyn Inc., please visit www.welchallyn.com

e-MedRecords

e-MedRecords is a Sparta, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ashley Ridge Imaging

Ashley Ridge Imaging is a Shreveport, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SynGen

SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.